Lastly, the drug sensitivity data from Genomics of Drug Sensitivity in Cancer (GDSC, version 17.3) showed osteosarcoma cell lines with various response to CDK6 or EGFR inhibitors (Figure S4). The gene discussed is EGFR; the disease is osteosarcoma.